Vertical: CNMBase Year: 2025
Market Size (2025)
$59.90M
Projected (2032)
$93.83M
CAGR (2022–2032)
6.7%
Key Players
12+
Market Overview
The Global Agrochemical Encapsulation Polymers Market was valued at USD 59.904 Million in 2025 and is projected to reach USD 93.835 Million by 2032, registering a CAGR of 6.61% during 2026–2032. The market expanded from USD 49.237 Million in 2022 to USD 56.127 Million in 2024, and is expected to add USD 33.931 Million in absolute terms between 2025 and 2032.
Agrochemical encapsulation polymers form the wall or matrix of microcapsules that enclose pesticide active ingredients in capsule suspension (CS), mixed capsule–suspension (ZC) and related controlled-release formulations. The polymer shell governs the release rate of the active ingredient, reduces volatility and operator exposure, protects light- or moisture-sensitive molecules and improves crop safety. Demand is therefore linked to the number of encapsulated formulations registered and sold by crop protection companies, rather than to the overall volume of pesticides consumed.
Key Findings
Polymer Type: Polyurea is the largest segment with a 50.0% share in 2025 (USD 29.952 Million), while Others is the fastest-growing segment at a CAGR of 7.48%.
Pesticide Type: Insecticides account for the largest share at 50.0% in 2025 (USD 29.952 Million), while Herbicides are the fastest-growing segment at a CAGR of 7.36%.
Region: Asia Pacific is the leading region with a 38.0% share in 2025 (USD 22.764 Million); Middle East & Africa is the fastest-growing region at a CAGR of 7.89%.
Country: The U.S. is the leading country market at USD 9.345 Million in 2025 (15.6% of the global market), while India is the fastest-growing country at a CAGR of 9.37%.
Segmentation Summary
By polymer type, the market is segmented into Polyurea, Polyurethane and Others. Polyurea, produced by interfacial polymerisation of isocyanates with amines or water, is the established wall chemistry for commercial capsule suspensions and held a 50.0% share in 2025. Polyurethane and Others each held a 25.0% share in 2025; however, Others, which include aminoplast, polyamide, natural and biodegradable polymers, are forecast to grow at 7.48% against 5.10% for Polyurethane, reflecting the regulatory push towards biodegradable capsule walls.
By pesticide type, the market is segmented into Insecticides, Herbicides and Others. Insecticides, led by encapsulated pyrethroids, held a 50.0% share in 2025, while Herbicides (35.0% share) are set to grow fastest at 7.36%, supported by encapsulated residual herbicides such as acetochlor, clomazone and pendimethalin.
Competitive Landscape Summary
The market is moderately consolidated. Value is concentrated among research-based crop protection companies that own proprietary encapsulation platforms, such as Syngenta Group (Zeon Technology), Bayer (encapsulated acetochlor), FMC (microencapsulated clomazone), Corteva (encapsulated acetochlor in Enversa) and BASF (capsule suspension pendimethalin and the encapsulated saflufenacil formulation in its pipeline). Formulation-led companies such as UPL and Sumitomo Chemical compete through proprietary capsule suspension technologies applied to off-patent actives. Upstream, isocyanate and amine producers such as Covestro and Huntsman supply the building blocks of polyurea and polyurethane walls, while specialist encapsulation companies such as Milliken (Encapsys) and Calyxia, and formulation additive suppliers such as Croda, address the shift towards biodegradable and biological-compatible capsules.
Challenges and Opportunities
The principal challenge is regulatory. The European Union restriction on intentionally added synthetic polymer microparticles (Commission Regulation (EU) 2023/2055) places conventional polyurea and polyurethane capsule walls under scrutiny and obliges formulators to plan reformulation within the applicable transition periods. Isocyanate handling requirements, raw material price volatility and the higher manufacturing cost of capsule suspensions relative to emulsifiable concentrates also constrain adoption, while the 2023–2024 destocking cycle in crop protection weighed on volumes.
The same pressures create opportunities. Biodegradable and bio-based wall materials, encapsulation of biological actives and pheromones, mixed capsule–suspension products that combine two actives in one container, and the continued registration of encapsulated generics in Asia Pacific and Latin America provide multiple avenues for growth.
Future Outlook
The market is expected to grow steadily from USD 63.921 Million in 2026 to USD 93.835 Million in 2032. Growth will be led by Asia Pacific, Latin America and the Middle East & Africa, where agricultural intensification and formulation upgrading continue, while North America and Europe will grow more slowly but remain important centres of innovation and regulation-driven reformulation. Over the forecast period, the polymer mix is expected to shift gradually towards Others, reflecting biodegradable chemistries, and the pesticide mix towards Herbicides.
The Agrochemical Encapsulation Polymers Market market is projected to grow at a CAGR of 6.7% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Agrochemical encapsulation polymers are film-forming or matrix-forming polymers used to enclose crop protection active ingredients in discrete particles, typically microcapsules of 1–50 micrometres, that release the active ingredient by diffusion through the wall, by rupture or by degradation of the wall after application. The capsule wall is most commonly formed in situ by interfacial polymerisation: an oil phase containing the active ingredient and a polyfunctional isocyanate is emulsified in water, and the isocyanate reacts at the droplet surface with water, amines or polyols to form a polyurea or polyurethane shell. Other wall systems are formed by in-situ polymerisation of aminoplast resins, by complex coacervation of natural polymers, or by matrix encapsulation in biodegradable polymers.
Included in the scope: polyurea, polyurethane and other polymers (including aminoplast resins, polyamides, cross-linked natural polymers such as gelatin, alginate, chitosan, starch and lignin, and biodegradable synthetic polymers such as polyesters) used as capsule walls or encapsulating matrices for insecticides, herbicides and other pesticides (fungicides, nematicides, acaricides, pheromones and other crop protection actives). The market is valued at the level of the encapsulating polymer used in these formulations.
Excluded from the scope: the value of the formulated pesticide products themselves; polymer coatings for controlled-release fertilisers; film-forming binders used in seed coatings that do not encapsulate an active ingredient; and dispersants, emulsifiers, thickeners and other formulation additives that do not form part of the capsule wall.
Scope of the Study
The study covers the global market for agrochemical encapsulation polymers, segmented as follows:
By Polymer Type: Polyurea, Polyurethane, Others
By Pesticide Type: Insecticides, Herbicides, Others
By Region: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia Pacific), Latin America (Brazil, Argentina, Rest of Latin America), Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA)
Timeline: historic years 2022–2024, base year 2025, forecast period 2026–2032
Unit: market value in USD Million; growth expressed as CAGR for 2026–2032
Research Objectives
To estimate the size of the global agrochemical encapsulation polymers market for 2022–2025 and forecast it to 2032 in USD Million.
To analyse the market by polymer type (Polyurea, Polyurethane, Others) and identify the wall chemistries gaining share.
To analyse the market by pesticide type (Insecticides, Herbicides, Others) and link demand to encapsulated formulation pipelines.
To assess regional and country-level demand across North America, Europe, Asia Pacific, Latin America and the Middle East & Africa.
To evaluate the impact of regulations, in particular restrictions on synthetic polymer microparticles and isocyanate handling, on polymer selection.
To identify drivers, restraints, opportunities and trends shaping demand for encapsulation polymers.
To map the value chain from isocyanate, amine and bio-based raw materials to formulators and end users.
To profile the competitive environment and track key developments of leading companies since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured, multi-stage research process. It began with a definition of the market scope and segmentation, followed by extensive secondary research to build a fact base on encapsulated formulation registrations, pesticide consumption, polymer chemistries and company activity. Primary research with participants across the value chain was then used to validate assumptions, refine segment splits and test forecast drivers. Market estimates were derived through top-down and bottom-up approaches, reconciled through data triangulation and subjected to internal quality review before finalisation.
Secondary Research
Secondary research drew on sources relevant to the crop protection and specialty polymer industries, including:
Industry associations: CropLife International and regional crop protection associations, the European Crop Protection Association, and national pesticide manufacturer and formulator associations.
Government and regulatory bodies: pesticide registration databases and regulatory decisions of the U.S. Environmental Protection Agency, the European Commission, the European Food Safety Authority, the European Chemicals Agency, Health Canada's Pest Management Regulatory Agency, India's Central Insecticides Board & Registration Committee, China's Institute for the Control of Agrochemicals and Brazil's Ministry of Agriculture and Livestock.
Company filings: annual reports, investor presentations, product labels and technical bulletins of crop protection companies, isocyanate and amine producers, and encapsulation specialists.
Trade and scientific journals: publications on pesticide formulation, controlled release and microencapsulation, conference proceedings and patent literature on capsule wall chemistries.
Paid databases: trade statistics, company financial databases and agrochemical product registration databases.
Primary Research
Primary research was conducted through in-depth telephone and online interviews with industry participants on both the supply and demand sides. On the supply side, respondents included product managers, R&D and formulation scientists, and business development executives at isocyanate, amine and specialty polymer producers, encapsulation specialists and toll formulators. On the demand side, respondents included formulation and regulatory managers at crop protection companies, distributors of agrochemicals and agronomists.
The objectives of primary research were to validate the market definition and segmentation, verify estimates of polymer loading per unit of encapsulated formulation, understand price trends of wall materials, assess the impact of regulations on polymer selection, and gather qualitative insights on competitive dynamics and future demand.
Market Size Estimation
Top-down approach: The global crop protection market was used as the starting point. The share of capsule suspension and related encapsulated formulations was estimated by pesticide type and region, and the polymer value was derived by applying typical wall-material loading and polymer price assumptions.
Bottom-up approach: Consumption of encapsulation polymers was built up by country from the volumes of major encapsulated formulations (for example, encapsulated pyrethroids, clomazone, acetochlor and pendimethalin), the polymer content of each formulation and prevailing wall-material prices, and aggregated to regional and global totals.
Data triangulation: Results of the two approaches were compared and reconciled with supply-side indicators such as the agricultural sales of encapsulation specialists and isocyanate consumption in formulation applications. Differences were investigated and resolved through additional primary interviews.
Forecasting Methodology
Forecasts were developed for each segment and country by modelling the outlook for crop protection demand, the expected penetration of encapsulated formulations and the shift in wall chemistries. Factors considered include agricultural acreage and crop prices, pest and weed pressure, herbicide resistance, regulatory actions affecting active ingredients and polymer microparticles, new product registrations, raw material price trends and macroeconomic indicators. Forecasts were reviewed with industry experts and expressed as compound annual growth rates for 2026–2032.
Base Year, Forecast Period and Currency
Assumptions and Limitations
Market values reflect the value of encapsulating polymers and not the value of the formulated pesticide products.
Regulatory frameworks, including transition periods under the EU restriction on synthetic polymer microparticles, are assumed to apply as currently adopted.
No major disruption to global agricultural trade or isocyanate supply is assumed beyond normal cyclical fluctuations.
Polymer loading and price assumptions are averages across formulations and may differ for individual products.
Company-level data on encapsulated product sales is rarely disclosed, so segment splits rely partly on expert estimates.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The Global Agrochemical Encapsulation Polymers Market is moderately consolidated. Because most capsule walls are formed in situ during formulation, a large share of market value is controlled by research-based crop protection companies that own proprietary encapsulation platforms and branded capsule suspension products. These companies source isocyanates, amines, polyols and formulation additives from chemical producers, and increasingly work with encapsulation specialists to develop biodegradable or biological-compatible capsules.
Competition is based on release performance, crop safety, regulatory compliance, intellectual property and the ability to support registrations across multiple countries, rather than on polymer price alone. The industry is also undergoing significant structural change: Corteva completed the separation of its seed business in October 2026, BASF is preparing its Agricultural Solutions business for a potential listing, UPL is reorganising its crop protection business into a separately listed company, FMC is reviewing strategic options, Covestro was acquired by ADNOC's investment company XRG in December 2025, and Huntsman announced a merger with Olin in June 2026.
Key Player Positioning
Based on product portfolio in encapsulated formulations, technology ownership, geographic reach and strategic activity, the leading companies are positioned as follows.
Leaders
Syngenta Group (Switzerland/China; FY2025 sales of USD 28.4 billion, of which Crop Protection USD 13.7 billion): owner of Zeon Technology, a microencapsulated lambda-cyhalothrin platform sold as Warrior II and Karate Zeon, with a broad registration footprint and formulation capacity in China. Strategy combines crop protection volume growth with heavy investment in biologicals.
Bayer AG (Germany; FY2025 Group sales of EUR 45.575 billion, Crop Science EUR 21.622 billion): markets the Warrant, Warrant Ultra and Degree Xtra encapsulated acetochlor herbicides. Bayer is shifting crop protection production away from generic actives towards differentiated technologies.
BASF SE (Germany; FY2025 Group sales of EUR 59,657 million, Agricultural Solutions EUR 9.6 billion): offers capsule suspension pendimethalin (Prowl H2O, Stomp Aqua) and has an encapsulated saflufenacil formulation (Kixor CS) in its pipeline, alongside agrochemical formulation additives. BASF is preparing Agricultural Solutions as a standalone company.
Corteva Agriscience (U.S.; FY2025 net sales of USD 17,401 million, Crop Protection USD 7,503 million): launched Enversa herbicide based on encapsulated acetochlor and received EPA approval for Enclosa in 2026. Following the separation of its seed business, Corteva is a pure-play crop protection company.
FMC Corporation (U.S.; FY2025 revenue of USD 3,467.4 million): markets microencapsulated clomazone (Command 3ME, Gamit 36 CS). FMC is ramping up new active ingredients while reviewing strategic options and reducing debt.
Challengers
UPL Ltd (India; FY26 revenue of INR 51,839 crore for the year ended March 2026): uses proprietary capsule suspension technology in RICEONE CS and SATELLITE HYDROCAP to differentiate off-patent actives. UPL is creating a separately listed crop protection company.
Sumitomo Chemical Co., Ltd. (Japan; FY2025 sales revenue of JPY 2,328.5 billion for the year ended March 2026, Agro & Life Solutions JPY 519.3 billion): holds microcapsule formulation technology and patents and is expanding in biorationals through FBSciences and Sumitomo Biorational Company.
Raw Material and Formulation Additive Suppliers
Covestro AG (Germany; FY2025 sales of EUR 12.9 billion): a leading producer of aromatic and aliphatic isocyanates (Desmodur) and polyols (Desmophen), the building blocks of polyurea and polyurethane walls; now majority-owned by XRG and expanding MDI capacity.
Huntsman Corporation (U.S.; FY2025 revenues of USD 5,683 million): supplies MDI and JEFFAMINE polyetheramines used as polyurea raw materials; announced an all-stock merger with Olin in June 2026.
Croda International Plc (U.K.; FY2025 sales of GBP 1,699.4 million): supplies polymeric dispersants such as Atlox 4913 and adjuvants used to stabilise capsule suspensions, and is developing microplastic-free seed enhancement technologies.
Niche and Specialist Players
Milliken & Company (Encapsys) (U.S.; privately held, revenue not publicly disclosed): Encapsys brings more than 65 years of microencapsulation experience, with interfacial, in-situ and coacervation technologies and biodegradable options; it expanded agricultural encapsulation capabilities to Brazil in 2025.
Calyxia SAS (France; privately held, revenue not publicly disclosed): developer of NaturaCaps biodegradable microcapsules for crop protection and biosolutions, positioned as a replacement for synthetic polymer microcapsules; raised USD 35 million in a Series B round in 2024.
Threat of New Entrants – Medium
Encapsulation know-how, patents on wall chemistries and the cost of regulatory data for new formulations create meaningful barriers.
Venture-funded specialists such as Calyxia show that new entrants can enter through differentiated biodegradable technologies.
Established relationships between polymer suppliers and crop protection companies favour incumbents.
Bargaining Power of Suppliers – Medium to High
Global isocyanate production is concentrated among a small number of producers, including Covestro, BASF, Huntsman, Dow and Wanhua Chemical.
Agrochemical encapsulation is a small outlet for isocyanate producers, limiting the leverage of formulators.
Natural and bio-based wall materials are available from a broader supplier base, which moderates supplier power for the Others segment.
Bargaining Power of Buyers – High
Buyers are large crop protection companies with strong purchasing power and in-house formulation expertise.
Many buyers produce capsule walls in situ from commodity monomers, which allows them to switch suppliers.
Price pressure in generic crop protection markets is passed back to polymer suppliers.
Threat of Substitutes – Medium
Alternative formulation types (suspension concentrates, oil dispersions, water-dispersible granules) can meet some safety needs without encapsulation.
Seed treatments and biological products can replace some foliar applications.
For volatile or highly toxic actives, encapsulation has few effective substitutes.
Intensity of Competitive Rivalry – Medium to High
Competition centres on release performance, regulatory compliance and cost rather than polymer price alone.
Leading crop protection companies compete through proprietary encapsulation platforms and branded products.
The shift to biodegradable walls is opening a new field of technological competition.
Threat of New Entrants: Medium; Know-how and regulatory barriers, offset by biodegradable technology entrants.
Bargaining Power of Suppliers: Medium to High; Concentrated isocyanate supply; broader base for bio-based materials.
Bargaining Power of Buyers: High; Large, technically capable crop protection buyers.
Threat of Substitutes: Medium; Alternative formulation types and biologicals.
Competitive Rivalry: Medium to High; Proprietary platforms and new sustainable chemistries.
Market estimates by geography (2032)
InsightAsia Pacific leads with $37.30M by 2032, while Middle East & Africa is projected to grow fastest at a 7.6% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $10.14M | $13.31M | $17.35M | 5.5% | 18% |
| Europe | $8.25M | $10.52M | $13.32M | 4.9% | 14% |
| Asia Pacific | $18.27M | $26.29M | $37.30M | 7.4% | 40% |
| Latin America | $10.61M | $15.26M | $21.77M | 7.5% | 23% |
| Middle East & Africa | $1.97M | $2.81M | $4.09M | 7.6% | 4% |
| Total | $49.24M | $68.19M | $93.83M | 6.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$93.83M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Polyurea | $47.76M | 7.0% | 51% |
| Others | $24.87M | 7.4% | 27% |
| Polyurethane | $21.20M | 5.2% | 23% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Agrochemical Encapsulation Polymers Market covering market dynamics, competitive landscape, and strategic outlook.
The Agrochemical Encapsulation Polymers Market market is projected to reach $93.83M by 2032, growing at 6.7% CAGR. The Polyurea segment holds the largest share.
Demand for agrochemical encapsulation polymers is shaped by the interaction of regulatory, agronomic, technological and economic forces. Regulations that limit operator exposure, volatility and off-target movement favour encapsulated formulations, while restrictions on synthetic polymer microparticles are changing the choice of wall material. This chapter analyses the factors influencing the market. The impact scores presented in Table 4.1 are analyst assessments, rated on a scale of 1 to 10 for three periods within the forecast horizon.
Regulatory Focus on Operator Safety, Volatility and Off-Target Movement
Pesticide regulators increasingly assess not only the hazard of an active ingredient but also the exposure created by its formulation. In the United States, the Environmental Protection Agency has expanded drift and runoff mitigation through its Endangered Species Act workplan and the herbicide and insecticide strategies, while in the European Union, Regulation (EC) No 1107/2009 requires that operator, worker and bystander exposure remain within acceptable levels. Encapsulation is one of the most effective formulation tools to meet these requirements. A polymer wall reduces dermal exposure to toxic actives such as pyrethroids, lowers the vapour pressure of volatile herbicides such as clomazone, which is known for off-target bleaching of neighbouring vegetation, and limits staining and crop injury associated with pendimethalin. Products such as FMC's Command 3ME (microencapsulated clomazone) and BASF's capsule suspension pendimethalin formulations illustrate how encapsulation keeps established actives on the market under stricter conditions. As re-registration cycles continue, formulators are expected to convert more emulsifiable concentrate products to capsule suspensions, directly increasing the consumption of polyurea, polyurethane and alternative wall polymers.
Formulation-Led Differentiation of Off-Patent Active Ingredients
A large share of global crop protection sales comes from off-patent active ingredients, and competition among generic suppliers is intense, particularly after the low-price imports from Asian manufacturers that affected the market in 2023–2025. Proprietary formulation technology has become a primary means of differentiation and lifecycle management. Encapsulation allows companies to extend residual activity, improve crop safety and create premium branded products from mature molecules. UPL's RICEONE CS and SATELLITE HYDROCAP, Bayer's Warrant family of encapsulated acetochlor herbicides and Syngenta's Zeon Technology for lambda-cyhalothrin are examples of brands built on encapsulation. Bayer's decision in 2025 to exit generic active ingredient production in Germany and concentrate on differentiated technologies reflects the same logic. Because new active ingredients are costly and slow to develop, companies are expected to continue investing in encapsulated versions of existing actives, supporting steady demand for wall polymers.
Herbicide Resistance and Demand for Residual Weed Control
The spread of herbicide-resistant weeds such as waterhemp and Palmer amaranth in the Americas has increased the use of pre-emergence and layered residual herbicides in soybean, corn and cotton. Encapsulated acetochlor products provide extended residual control with improved crop safety, enabling application before and after crop emergence. Corteva launched Enversa herbicide, based on encapsulated acetochlor, in 2024, and received EPA approval in 2026 for Enclosa, which extends the same encapsulation technology to a mixture with cloransulam. Bayer's Warrant Ultra combines encapsulated acetochlor with fomesafen. In Brazil and Argentina, the largest soybean producers, similar resistance pressure is driving demand for residual herbicide programmes. These trends explain why Herbicides are the fastest-growing pesticide segment in the market and are expected to sustain demand for encapsulation polymers throughout the forecast period.
Agricultural Intensification and Formulation Upgrading in Emerging Markets
Asia Pacific and Latin America together account for the majority of the market, and both regions are increasing crop protection intensity to raise yields on limited land. China and India have large and growing formulation industries, and government institutions such as India's Institute of Pesticide Formulation Technology actively promote capsule suspension technology to domestic formulators. Multinational companies are adding formulation capacity in these regions, as illustrated by Syngenta's crop protection formulation plant in Nantong, China, which began operating in January 2026. Brazil, the largest crop protection market in the world, modernised its pesticide registration framework through Law No. 14,785 of 2023, which is expected to speed up product approvals. As farmers in these regions shift from older formulation types to safer and more convenient water-based products, the consumption of encapsulation polymers is expected to grow faster than in mature markets.
Biodegradable and Bio-Based Wall Materials
The restriction on synthetic polymer microparticles has created demand for capsule walls that are biodegradable or of natural origin. Specialist companies are responding: Calyxia has developed its NaturaCaps biodegradable microcapsules for agriculture and raised a USD 35 million Series B round in 2024 to expand production, while Milliken's Encapsys business offers biodegradable microcapsule options. Success in this area requires matching the release performance and storage stability of polyurea, and suppliers that achieve this are positioned to capture share as formulators reformulate. This opportunity underpins the above-average growth forecast for the Others polymer segment.
Encapsulation of Biologicals, Pheromones and Sensitive Actives
Biological crop protection products, including microbial agents, botanical extracts and semiochemicals, are often sensitive to ultraviolet light, temperature and moisture. Encapsulation can extend their shelf life and field persistence. Leading crop protection companies are investing heavily in biologicals, as shown by Corteva's acquisitions of Stoller and Symborg in 2023, Syngenta's expansion of biological production and Sumitomo Chemical's consolidation of its biorational businesses. Milliken extended its agricultural encapsulation capabilities to Brazil in 2025 and signed a research agreement with a Brazilian biologicals company, indicating the commercial potential of this application.
Mixed Formulations and New Active Ingredients
Mixed capsule–suspension (ZC) products and pre-mixes that combine an encapsulated active with a second active in a single container offer farmers convenience and broader-spectrum control. New active ingredients entering the market, including new herbicide modes of action, also create opportunities for encapsulated formulations that manage crop safety or volatility from launch. BASF's pipeline includes an encapsulated formulation of saflufenacil for rice (Kixor CS), illustrating how encapsulation is being designed into new products.
Restrictions on Synthetic Polymer Microparticles
Commission Regulation (EU) 2023/2055 restricts the placing on the market of synthetic polymer microparticles, a category that captures many conventional polyurea, polyurethane and aminoplast capsule walls. Plant protection products benefit from a transition period, but the regulation obliges formulators to report and progressively to reformulate, raising development and registration costs. Because reformulated products may require new efficacy and safety data, the restriction slows the launch of new capsule suspensions in Europe and contributes to the region's lower growth rate. Similar debates on microplastics in other jurisdictions add uncertainty for global formulators.
Isocyanate Handling Requirements and Raw Material Volatility
Polyurea and polyurethane walls are produced from isocyanates, which are respiratory sensitisers. Under the EU REACH restriction on diisocyanates (Commission Regulation (EU) 2020/1149), industrial and professional users have been required since August 2023 to complete training before handling these substances. Isocyanate prices also follow petrochemical feedstock and capacity cycles, and producers such as Covestro and Huntsman experienced weak demand and price pressure in 2024–2025. These factors increase the cost and complexity of in-house encapsulation for smaller formulators.
Higher Cost and Technical Complexity of Capsule Suspensions
Capsule suspensions are more expensive to develop and manufacture than emulsifiable concentrates or suspension concentrates. Control of capsule size, wall thickness and long-term physical stability requires specialised equipment and know-how, and the price premium is difficult to recover in price-sensitive generic markets, especially during periods of channel destocking such as the one the crop protection industry experienced in 2023–2024.
Shift from Solvent-Based to Water-Based Formulations
Formulators are moving away from solvent-based emulsifiable concentrates towards water-based formulations to reduce solvent exposure, flammability and odour. Capsule suspensions, being water-based dispersions, benefit directly from this trend.
Structural Change Among Crop Protection Companies
The industry is undergoing significant restructuring. Corteva completed the separation of its seed business in October 2026, BASF is preparing its Agricultural Solutions business for a possible initial public offering, UPL announced a reorganisation into a separately listed crop protection company in 2026, and FMC began a review of strategic options in 2026. These changes may reshape formulation portfolios and procurement of encapsulation polymers.
Localisation of Formulation Capacity
Companies are adding formulation and encapsulation capabilities close to major demand centres in China, India and Brazil, as shown by Syngenta's Nantong plant, Croda's new manufacturing site in Dahej, India, and Milliken's encapsulation laboratory in Brazil. Localisation shortens supply chains and supports registration of region-specific products.
Challenge of Matching Performance with Sustainable Chemistries
Replacing polyurea and polyurethane walls with biodegradable alternatives without loss of release control, storage stability or efficacy remains technically demanding. Regulatory data requirements for reformulated products add time and cost, making this the principal technical challenge for the market over the forecast period.
Feb 2022: Croda International; Partnership; Partnered with Xampla on a U.K. government-backed trial of microplastic-free, biodegradable seed coatings.
2022: Croda International; Expansion; Added manufacturing capacity for the Atlox 4913 polymeric dispersant in Campinas, Brazil.
Feb 2023: Sumitomo Chemical; Acquisition; Agreed to acquire FBSciences, a U.S. developer of naturally derived biostimulants and biopesticides.
Mar 2023: Corteva Agriscience; Acquisition; Completed the acquisitions of biologicals companies Stoller and Symborg.
Mar 2023: BASF SE; Product Pipeline; Presented its Agricultural Solutions pipeline, including Kixor CS, an encapsulated saflufenacil formulation for rice.
Mar 2023: Calyxia; Funding; Awarded a France 2030 i-Démo grant for its NaturaCaps biodegradable microcapsule project.
Aug 2023: Bayer AG; Expansion; Announced a EUR 220 million crop protection R&D facility in Monheim, Germany.
Feb 2024: Corteva Agriscience; Product Launch; Launched Enversa herbicide, based on encapsulated acetochlor, for soybean, cotton, corn and sorghum.
Feb 2024: Syngenta Group; Expansion; Signed an agreement to build a crop protection formulation plant in Nantong, China.
Apr 2024: UPL Ltd; Acquisition; Completed the acquisition of Corteva's solo mancozeb business in selected markets, including the Dithane brand.
Jul 2024: FMC Corporation; Divestment; Agreed to sell its Global Specialty Solutions business to Envu for USD 350 million.
Sep 2024: Calyxia; Funding; Raised USD 35 million in a Series B round to scale biodegradable microcapsule production.
Feb 2025: Sumitomo Chemical; Acquisition; Took full ownership of Philagro Holding and agreed to acquire Kenogard to strengthen European distribution.
Feb 2025: Syngenta Group; Acquisition; Acquired a repository of natural compounds and strains from Novartis for agricultural use.
May 2025: Bayer AG; Restructuring; Announced the refocusing of German crop protection production on strategic technologies and exit from generic active ingredients.
Jul 2025: Milliken & Company (Encapsys); Expansion / Partnership; Launched agricultural encapsulation capabilities in Brazil and signed an R&D agreement with IdeeLab.
Oct 2025: Sumitomo Chemical; Restructuring; Announced the merger of Valent BioSciences, MGK and Valent North America into Sumitomo Biorational Company.
Nov 2025: BASF SE; Corporate; Selected the Frankfurt Stock Exchange for a planned listing of its Agricultural Solutions business.
Dec 2025: Covestro AG; Acquisition; XRG, the investment company of ADNOC, completed the acquisition of a majority stake in Covestro.
Jan 2026: Syngenta Group; Expansion; Started operation of its crop protection formulation plant in Nantong, China.
Feb 2026: UPL Ltd; Restructuring; Announced a reorganisation to create UPL Global, a separately listed crop protection company.
Feb 2026: FMC Corporation; Corporate; Launched a review of strategic options, including a potential sale of the company.
Mar 2026: Croda International; Expansion; Opened a greenfield manufacturing site in Dahej, India, supporting crop protection growth in Asia.
May 2026: BASF SE; Expansion; Commissioned the BioHub fermentation plant for biological crop protection in Ludwigshafen.
May 2026: FMC Corporation; Divestment; Agreed to sell its India commercial business to Crystal Crop Protection for USD 252 million.
Jun 2026: FMC Corporation and Corteva; Partnership; Signed a co-exclusive supply and licence agreement for the herbicide rimisoxafen in the Americas.
Jun 2026: Huntsman Corporation; Merger; Announced an all-stock merger of equals with Olin Corporation.
Jun 2026: Covestro AG; Expansion; Announced plans for a world-scale MDI plant in China and a feasibility study in the UAE.
Aug 2026: Corteva Agriscience; Product Approval; Received EPA approval for Enclosa herbicide, extending its acetochlor encapsulation technology.
Oct 2026: Corteva Agriscience; Corporate; Completed the spin-off of its seed business, Vylor, becoming a pure-play crop protection company.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 32 companies operating in the Agrochemical Encapsulation Polymers Market market, including revenue, employee count, and market positioning where available.
Showing 32 of 32 companies
FMC Corporation is a Philadelphia-based, pure-play crop-protection company and one of the tier-one research-based agrochemical innovators, alongside Syngenta, Bayer, BASF and Corteva. It discovers, develops, manufactures and markets insecticides, herbicides, fungicides and "Plant Health" products (biologicals, crop nutrition, seed treatment) through distributors, retailers, cooperatives and, increasingly, direct-to-grower channels in Brazil. Its economic franchise was built on the diamide insecticides acquired from DuPont in 2017: Rynaxypyr® (~USD 0.8bn of FY2025 sales) and Cyazypyr® (~USD 0.4bn). Both have now lost core patent protection. FMC is therefore in a deep transition. FY2025 revenue fell to USD 3.47bn and the company booked a USD 2.24bn GAAP loss. It has cut the dividend 86%, fallen to junk credit status, and in 2026 raised capital through asset sales, a Corteva licence and a 20% equity stake sale to Tessenderlo Group. The equity case now rests on four new-mode-of-action active ingredients: Isoflex®, fluindapyr, Dodhylex™ and rimisoxafen. --- ### Company's own description (FY2025 10-K, paraphrased) FMC describes itself as a global agricultural sciences company that supplies farmers with innovative solutions to increase the productivity and resilience of their land, and states that it operates in a single business segment. It develops, markets and sells all three major classes of crop-protection chemicals (insecticides, herbicides and fungicides), together with biologicals, crop nutrition and seed-treatment products grouped as "Plant Health." The 10-K calls FMC a "tier-one leader" in agrochemicals, positioned through technology, geographic balance and crop diversity. For 2026 it sets four operational priorities: - strengthening the balance sheet; - improving competitiveness of the core portfolio; - managing the post-patent Rynaxypyr® transition; - supporting the growth of new active ingredients. ### Business model and revenue model | Dimension | Characterization | Evidence | |---|---|---| | Revenue model | Overwhelmingly product sales of formulated crop-protection products and active ingredients (AIs) | 10-K FY2025 product table | | Service revenue | Immaterial; Arc™ farm intelligence (precision-ag platform) is a commercial support tool, not a disclosed revenue line | 10-K FY2025 | | Licensing / supply revenue | Growing: cost-plus diamide supply to partners; Albaugh licence on chlorantraniliprole process (Nov 2024); Corteva rimisoxafen co-exclusive supply and licence with a USD 200M prepayment (Jun 2026); India supply agreement with Crystal Crop on close | 10-K FY2025; Q4 FY2025 release; 10-Q Q2 FY2026 | | Subscription | None disclosed | — | | Product mix (FY2023, latest disclosed split) | Insecticides ~59%, herbicides ~29%, fungicides ~7%, Plant Health ~4%, other ~1% | 2023 Corporate Fact Sheet (label mapping inferred from chart) | | Portfolio framing | "Core" portfolio = Rynaxypyr® plus legacy off-patent herbicides and insecticides. "Growth" portfolio = Cyazypyr®, the four new AIs and Plant Health | Q4 FY2024 release footnote; 10-K FY2025 | ### Value-chain position FMC is a discovery-to-formulation innovator that relies heavily on outsourcing. It owns large-scale AI plants in: - Mobile, Alabama (USA) - Manati, Puerto Rico - Jinshan, China - Rønland, Denmark - Panoli, India It also sources "critical intermediates and finished products" largely from third parties in China and India (10-K FY2025 risk factors). Downstream, it sells through: - distributors, retailers and cooperatives in all four regions; - direct sales to large growers in Brazil, an expanding channel cited as a Q4 FY2026 growth driver; - alliance partners, including diamide partners on "cost-plus" contracts. ### Customer types and end-markets Customers are agricultural distributors and retailers, co-ops, large growers (Brazil), and other agrochemical companies that buy diamide AI under supply contracts. End-markets are row crops (soybean, corn, cotton, sugarcane, rice, cereals) and specialty crops (fruits, vegetables, tree nuts). Non-crop uses (pest control, turf) were largely exited with the sale of the Global Specialty Solutions business in November 2024. Demand is seasonal. Northern-hemisphere demand runs March–September, weighting Q1/Q2. Southern-hemisphere demand runs July–February, weighting Q3, Q4 and Q1 (10-K FY2025). ### Independent characterization FMC is a mid-sized research-based agrochemical company. It has a disproportionately concentrated franchise: the diamides were roughly 35% of FY2025 GAAP revenue (USD ~1.2bn of USD 3.47bn). The company is now caught between generic-driven price deflation on its legacy molecules and a still-sub-scale new-AI portfolio (USD ~200M in FY2025). It also faces an unusually leveraged balance sheet for a company of its size. Its strategy has shifted from "growth and returns" (2021–2023) to "survival and re-base" (2025–2026): - monetize IP through partners (Corteva); - shrink the manufacturing footprint (Project Foundation); - exit structurally unprofitable markets (India commercial); - recapitalize via a strategic minority investor (Tessenderlo).
Huntsman is a mid-cap, globally diversified manufacturer of differentiated chemicals, organised around three segments. The largest is Polyurethanes, built on MDI (methylene diphenyl diisocyanate) and downstream systems, which accounts for roughly 65% of segment revenue. The other two are Performance Products, covering amines, maleic anhydride and catalysts, and Advanced Materials, covering epoxy, acrylic and polyurethane-based adhesives, composites and formulations for aerospace, power and industrial markets. Management's thesis since 2018 has been to move away from commodities and towards downstream, formulated and specified products tied to energy efficiency and lightweighting. Management has said these themes touch about two-thirds of sales. That repositioning was executed through divestitures (Venator, Chemical Intermediates & Surfactants, Textile Effects) and bolt-on acquisitions. It was then overwhelmed by a severe and prolonged chemical down-cycle. Adjusted EBITDA fell from USD 1.34 billion in FY2021 to USD 275 million in FY2025, the dividend was cut 65%, and the credit rating fell to sub-investment grade. The company's answer is an all-stock merger of equals with upstream chlor-alkali/epoxy producer Olin, which creates the vertically integrated "OlinHuntsman". --- ### Company self-description In its FY2025 earnings release (Feb 2026), Huntsman describes itself as a publicly traded global manufacturer and marketer of differentiated and specialty chemicals. It reported roughly USD 6 billion of 2025 revenue from continuing operations and sells thousands of chemical products worldwide to manufacturers serving consumer and industrial end markets [V]. The 10-K for FY2025 (filed February 2026) frames the business across three reportable segments: Polyurethanes, Performance Products and Advanced Materials. ### Independent characterisation Huntsman is best understood as a mid-stream to downstream chemical converter with one large semi-commoditised profit pool (MDI) and two smaller specialty franchises. The three businesses have different economics: **Polyurethanes (≈65% of FY2025 segment revenue):** is a scale business anchored by MDI production at Geismar (Louisiana, USA), Rotterdam (Netherlands) and Caojing (Shanghai, China, through joint ventures). Huntsman's strategy is to push as much MDI as possible into "differentiated" downstream systems: spray-foam insulation (Huntsman Building Solutions), automotive foams and composites, TPU elastomers, and footwear and furniture systems. These systems carry better and stickier margins than component MDI. Even so, segment profitability tracks the global MDI supply/demand balance. That balance has been structurally weakened by Chinese capacity additions, led by Wanhua. **Performance Products (≈17%):** makes amines (ethyleneamines, polyetheramines sold as JEFFAMINE), catalysts, carbonates and maleic anhydride. It is US-centred, with key sites on the Texas/Louisiana Gulf Coast plus Petfurdo in Hungary. Its end markets are coatings, composites, fuels and lubricants, agriculture, construction and electronics. The European maleic anhydride plant at Moers (Germany) was closed in 2025. **Advanced Materials (≈18%):** is the highest-quality franchise. It includes the ARALDITE adhesives and epoxy systems heritage, inherited from Ciba via Vantico, and serves aerospace, power transmission and distribution, automotive, electronics and industrial markets. It has consistently delivered segment adjusted EBITDA margins of about 16–20% and is the most resilient segment through the cycle. ### Revenue model | Revenue type | Assessment | |---|---| | Product sales | ~100% of revenue. Huntsman sells physical chemical products under spot, contract and formula-priced arrangements. | | Services | Immaterial. Technical service is bundled with product (e.g., spray-foam contractor training through Huntsman Building Solutions). | | Subscription | None | | Licensing / royalties | Immaterial and not separately disclosed | | Tolling / by-products | Disclosed as excluded from price/volume analysis. Small and not separately quantified. | | Equity income | Material in Polyurethanes, mainly from the minority-owned China MDI JV. Equity income in unconsolidated affiliates was USD 83M in FY2023, USD 44M in FY2024 and USD 4M in FY2025 [V]. | ### Value-chain position Upstream, Huntsman buys benzene, nitric acid/aniline inputs, chlorine/caustic, propylene oxide/polyols feedstocks, ethylene oxide/ethylene, natural gas and n-butane for maleic. It is not integrated into chlorine or epoxy building blocks (epichlorohydrin, bisphenol-A liquid epoxy resin). This gap is the core industrial logic of the Olin merger, since Olin is a leading chlor-alkali and epoxy producer. Downstream, Huntsman sells to formulators, OEMs and contractors. ### Customer types and end markets **Customers:** OEMs (automotive, aerospace, appliance, electrical equipment), formulators (coatings, adhesives, composites), construction product makers (insulation boards, spray-foam contractors, OSB/engineered wood), and industrial processors (footwear, furniture, lubricants, fuel additives). **End markets (management characterisation):** construction and insulation (the largest exposure), automotive and transportation, aerospace, power/electrical, industrial, consumer (footwear, furniture, bedding), energy (fuels and lubricants), and electronics. **Structural theme:** Management states that energy efficiency and lightweighting affect about two-thirds of total sales (FY2023 Q4 release, Feb 2024) [V].
Company Headquarters: Indianapolis, US Founded: 1989 Workforce: ~21,100 Company Working: Corteva Agriscience develops, manufactures, and markets a wide range of products, including seeds and traits, crop protection, software, and digital solutions, seed treatments, forages, inoculants, vegetation management, pasture management, turf and ornamental, urban pest management, and oil. It is directly present in more than 50 countries and covers all major regions such as North America, Asia-Pacific, Latin America, Europe, and the Middle East & Africa. Corteva Agriscience is a subsidiary of Dow Chemical Company. Hence, the provided financial information is of the Dow Chemical Company.
Covestro is one of the world's largest producers of high-performance polymer materials and their precursors, built on Bayer's eight-decade legacy in polyurethane and polycarbonate chemistry. It sits in the upstream-to-midstream portion of the chemical value chain, converting petrochemical (and increasingly bio-based and recycled) feedstocks into isocyanates (MDI, TDI, HDI and aliphatic derivatives), polyols, polycarbonate resins and specialty systems for coatings, adhesives, elastomers and films. Roughly half of revenue comes from scale-driven commodity-like "Performance Materials" and half from customer-specific "Solutions & Specialties". After three years of cyclical trough (sales down from €18.0bn in 2022 to €12.9bn in 2025 and net losses each year), Covestro was acquired by ADNOC's international chemicals vehicle XRG in a ~€14.7bn transaction completed in late 2025, giving it a deep-pocketed, feedstock-integrated strategic owner. Its strategic thesis is "Sustainable Future": leadership in circular, climate-neutral polymers, now combined with Gulf-based capacity growth. --- ### What the company does Covestro manufactures polymer materials and components. Its chemistry falls into three technology families: 1. **Polyurethanes (PU)** — isocyanates (MDI for rigid foams, TDI for flexible foams) and polyether polyols, sold to foam makers for insulation (construction, refrigeration/cold chain) and comfort (furniture, mattresses, automotive seating). 2. **Polycarbonates (PC)** — engineering thermoplastic (Makrolon® brand) and compounds/blends (Bayblend®, Makroblend®) for automotive, electrical & electronics, healthcare, lighting and construction glazing. 3. **Coatings, Adhesives & Specialties** — aliphatic isocyanates and derivatives (HDI, IPDI, H12MDI; Desmodur®), polyols/resins (Desmophen®, Bayhydrol®), the former DSM Resins & Functional Materials portfolio (NeoCryl®, NeoRez®, Decovery®), thermoplastic polyurethanes (Desmopan®), elastomers, and specialty films (Makrofol®, Platilon®). ### Business model and revenue model **Product sales ≈ ~100% of revenue:** Covestro does not report material service, subscription or licensing revenue; technology licensing and engineering services are incidental (n/d as a separate line). **Performance Materials:** behaves as a cost-leadership, scale business with prices set by global supply/demand for MDI/TDI/polyols/PC; margins swing sharply with industry utilisation and raw material (benzene, toluene, propylene, chlorine, natural gas, energy) spreads. **Solutions & Specialties:** is a formulation- and application-driven business: tailored grades, technical service, co-development with OEMs, stickier pricing and higher, more stable margins. ### Value-chain position Upstream: buys aromatics (benzene, toluene), propylene, natural gas/energy, chlorine (partly produced in-house via chlor-alkali electrolysis), phenol/acetone/bisphenol A inputs. Midstream: isocyanate, polyol and PC production at large integrated "world-scale" sites (Leverkusen, Dormagen, Krefeld-Uerdingen, Antwerp, Baytown, Shanghai, Tarragona, Map Ta Phut). Downstream: sells mostly B2B to converters (foam producers, compounders, coaters, adhesive formulators) and OEMs. ### Customer types and end-markets Covestro's largest end-markets (historically disclosed shares; latest split n/v) are construction (insulation, floor coatings), automotive & transportation (seating, interiors, lighting, coatings, e-mobility battery housings), furniture & wood processing (mattresses, wood coatings), electrical & electronics (housings, displays), sports & leisure, cosmetics, healthcare (medical-grade PC and TPU), and chemicals/industrial. ### Company self-description (latest annual reporting, paraphrased) Covestro describes itself as one of the world's leading manufacturers of high-quality polymer materials and their components, pursuing a vision of becoming fully circular and supporting customers' sustainability goals ("Sustainable Future" strategy). Every investor release in 2026 closes with: sales €12.9bn in FY2025, 46 production sites, ~17,600 FTE. ### Independent characterisation Covestro is fundamentally a cyclical isocyanates/polycarbonate producer with a growing specialty overlay. Its earnings power is dominated by MDI and PC margins, which collapsed in 2022–2025 due to Chinese capacity additions (notably Wanhua), weak European construction, high German energy costs and soft durable-goods demand. Its strategic differentiators are (a) technology leadership and process efficiency in MDI/TDI/PC, (b) one of the broadest aliphatic isocyanate franchises globally (coatings & adhesives), and (c) an early-mover position in circular feedstocks (chemical recycling of PU foam and PC, bio-attributed MDI/PC). Under XRG ownership, the investment case shifts from public-market equity story to an integrated Gulf-feedstock growth platform, evidenced by the July 2026 MDI expansion program in China and the UAE.
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
Bayer is a German life-science group with three businesses: Crop Science, Pharmaceuticals and Consumer Health. It is the world's largest combined seed, trait and crop-protection supplier, a mid-sized prescription-drug maker, and a top-five self-care company. Fiscal 2025 sales were EUR 45.6 billion. The 2018 purchase of Monsanto brought leading corn and soybean genetics but also glyphosate and PCB litigation, which has consumed well over EUR 10 billion in settlements and produced net losses in 2023, 2024 and 2025. Under CEO Bill Anderson the company has cut management layers, held the dividend at the legal minimum, and concentrated on four priorities: rebuilding the pharma pipeline, containing litigation, reducing debt and improving crop profitability. In 2026 a 7–2 U.S. Supreme Court ruling on federal pre-emption and a proposed USD 7.25 billion class settlement moved the litigation closer to resolution, though the settlement still awaits final court approval. --- **Company's own description.** Bayer describes itself as a global enterprise with core competencies in the life-science fields of health care and nutrition, operating under the mission "Health for all, Hunger for none" (Annual Report 2025; press boilerplate 2026). Bayer AG is a holding company; operations sit in subsidiaries worldwide. In fiscal 2025 the Group had about 88,000 employees, sales of EUR 45.6 billion and R&D expenses of EUR 5.8 billion. **Independent characterisation.** Bayer is best understood as three distinct businesses sharing a balance sheet, a brand and a legal liability. Crop Science (47 percent of FY2025 sales) is an input supplier to farmers. It earns money from proprietary seed and biotech traits, from chemical and biological crop protection, and to a small extent from digital farming subscriptions. Seed and trait revenue carries royalty-like economics: Bayer licenses traits to other seed companies, and two licensing settlements with Corteva lifted results in Q4 2025 and Q1 2026. The business is strongly seasonal, with Northern Hemisphere sales concentrated in the first half and Latin American sales in the second. Pharmaceuticals (39 percent of sales) discovers, develops and sells prescription medicines, concentrated in cardiovascular and renal disease, oncology, women's health and ophthalmology, plus a radiology unit selling contrast agents and injector hardware. Revenue is almost entirely product sales, with some licence income (for example U.S. Xarelto royalties from Johnson & Johnson, and Eylea outside the United States under a collaboration with Regeneron). The division is in the middle of a patent transition: Xarelto and Eylea are declining while Nubeqa and Kerendia are growing quickly. Consumer Health (13 percent of sales) sells non-prescription brands through pharmacies, mass retail and e-commerce. It is a branded consumer-goods model with stable margins and low capital intensity. **Revenue model mix.** Bayer does not disclose a product/service/licensing split. On the evidence of the Annual Report 2025, the large majority of revenue is product sales; licensing income is embedded in Crop Science seed and trait lines and in Pharmaceuticals; subscription revenue (Climate FieldView, radiology software) is immaterial at Group level. An exact percentage split is not publicly disclosed. **Value-chain position.** Bayer is a research-based originator and manufacturer. It owns discovery, development, active-ingredient and finished-product manufacturing, and commercial organisations, and sells through distributors, retailers, wholesalers, hospitals and pharmacies rather than directly to end users in most markets. **Customers and end markets.** Farmers, agricultural retailers and distributors, and seed licensees (Crop Science); wholesalers, hospitals, physicians, pharmacy chains, governments and payers (Pharmaceuticals); pharmacies, supermarkets, drugstores and online retailers (Consumer Health).
58 interactive charts drawn from the Agrochemical Encapsulation Polymers Market dataset — market size, each segment breakdown, and every region and country by segment. Open one to read its full data table and download it.
Global Agrochemical Encapsulation Polymers Market By Region
Global Agrochemical Encapsulation Polymers Market By Polymer Type
Global Agrochemical Encapsulation Polymers Market By Pesticide Type
Global Agrochemical Encapsulation Polymers Market — North America by Country
Global Agrochemical Encapsulation Polymers Market — North America by Polymer Type — Market Value
Global Agrochemical Encapsulation Polymers Market — North America by Pesticide Type — Market Value
Global Agrochemical Encapsulation Polymers Market — U.S. by Polymer Type — Market Value
Global Agrochemical Encapsulation Polymers Market — U.S. by Pesticide Type — Market Value
Global Agrochemical Encapsulation Polymers Market — Canada by Polymer Type — Market Value
Global Agrochemical Encapsulation Polymers Market — Canada by Pesticide Type — Market Value
Global Agrochemical Encapsulation Polymers Market — Mexico by Polymer Type — Market Value
Global Agrochemical Encapsulation Polymers Market — Mexico by Pesticide Type — Market Value
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and forecast (2022–2032, USD Million)
Market Size (USD Million)
